Simon T. Barry

机构：AstraZeneca (United Kingdom), AstraZeneca (Singapore) · ORCID：0000-0002-8511-0588

发表论文 588 篇 · 总被引 14717 次 · h-index 60

代表论文

• MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance (2025 · Nature · 被引 32)
• KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer (2025 · Cancer Cell · 被引 24)
• Cell-intrinsic metabolic phenotypes identified in patients with glioblastoma, using mass spectrometry imaging of 13C-labelled glucose metabolism (2025 · Nature Metabolism · 被引 17)
• A linear ontogeny accounts for the development of naive, memory, and tumor-infiltrating regulatory T cells in mice (2025 · Science Immunology · 被引 6)
• The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer (2025 · npj Breast Cancer · 被引 6)
• Tumor-associated neutrophil precursors impair homologous DNA repair and promote sensitivity to PARP inhibition (2025 · Nature Communications · 被引 5)